Movianto, a leading European healthcare logistics provider and part of Yusen Logistics, today announced the opening of its new pharmaceutical logistics hub in Wiesloch, Germany.
Believed to be one of Europe’s largest pharmaceutical cold storage facilities, the new site enhances end-to-end healthcare supply chains across Europe, linking large-scale cold storage capacity with specialized healthcare last-mile delivery capabilities.
The new site adds 10,000 pallet positions at 2°C to 8°C. The facility also includes 2,400 pallet positions dedicated to deep-freeze storage at -20°C and -26°C and will offer ultra-low temperature capabilities of up to -80°C to support the increasingly complex requirements of vaccines, biologics and other temperature-sensitive healthcare products.
Located in VGP Park Wiesloch-Walldorf, near the intersection of the A5 and A6 motorways, the site comprises approximately 30,000 square meters of warehousing space and 1,500 square meters of office space. The warehouse officially opened in September 2026 and is expected to become fully operational in November 2026.
“Healthcare supply chains are becoming increasingly complex, with growing demand for temperature-controlled storage, specialist handling and reliable distribution,” said Bruno Jacques, Deputy Managing Director of Yusen Logistics (Europe) and CEO of Yusen Logistics Healthcare. “The opening of Wiesloch marks a major milestone in our strategy to build one of Europe’s most integrated healthcare logistics networks. This investment expands our capabilities, enhances supply chain resilience and helps ensure patients have access to critical healthcare products wherever they are needed.”
Like many Movianto sites across Europe, Wiesloch benefits from access to Euro-transpharma's dedicated healthcare distribution network, providing seamless access to specialized last-mile delivery services across nine European countries.
This integrated network combines pharmaceutical warehousing, temperature-controlled transport and specialized healthcare delivery services, enabling end-to-end supply chain solutions from storage to final delivery. Eurotranspharma's active dual-temperature fleet is capable of transporting products within both +15°C to +25°C and +2°C to +8°C temperature ranges simultaneously, supporting the growing needs of pharmaceutical and healthcare manufacturers throughout Europe.
“What makes Yusen Logistics Healthcare unique is our ability to provide seam-less end-to-end healthcare logistics solutions through dedicated specialist networks,” added Bruno Jacques. “The direct connection between Wiesloch and Eurotranspharma brings together large-scale pharmaceutical warehousing and specialized healthcare distribution, creating a reliable, compliant and efficient supply chain platform for customers across Europe.”
The facility has been purpose-built to support pharmaceutical and healthcare supply chains. The entire warehouse is temperature controlled and divided into multiple temperature zones, including ambient (15°C to 25°C), refrigerated (2°C to 8°C), deep-freeze (-20°C and -26°C) and future ultra-low temperature (-80°C) capabilities.
Movianto also plans to introduce Good Manufacturing Practice (GMP) operations within the refrigerated area, creating additional value-added capabilities for pharmaceutical customers requiring specialized handling and manufacturing support under strictly controlled temperature conditions.
According to Ingo Schlieper, Managing Director of Movianto’s DACH operations, the Wiesloch site represents a major investment in future healthcare logistics capacity. The facility is expected to employ up to 180 people and has been de-signed to support an inclusive working environment, including full accessibility throughout the site.
The new facility has been designed to meet the highest standards of security, quality and sustainability. Movianto is pursuing TAPA-A certification, the highest level of facility security under the Transported Asset Protection Association framework, demonstrating its commitment to protecting high-value and sensitive healthcare products.
The site has also achieved DGNB Gold certification and is pursuing DGNB Platinum certification, the highest rating awarded by the German Sustainable Building Council. Sustainability features include a heat pump system, LED lighting, rainwater management infrastructure and a high-capacity rooftop photovoltaic installation. The solar power system is expected to generate approximately 3,100 megawatt-hours of electricity annually, exceeding the facility’s projected energy consumption and contributing to a reduced carbon footprint.
